IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $805,000 | +32.8% | 9,474 | -44.6% | 0.00% | 0.0% |
| Q2 2020 | $606,000 | +224.1% | 17,106 | +23.1% | 0.00% | +200.0% |
| Q1 2020 | $187,000 | -53.1% | 13,900 | -26.5% | 0.00% | -50.0% |
| Q4 2019 | $399,000 | -1.2% | 18,900 | -38.2% | 0.00% | +100.0% |
| Q3 2019 | $404,000 | -59.2% | 30,600 | -57.2% | 0.00% | -75.0% |
| Q2 2019 | $991,000 | -29.7% | 71,451 | -2.6% | 0.00% | -33.3% |
| Q1 2019 | $1,409,000 | +28.9% | 73,351 | -4.3% | 0.01% | 0.0% |
| Q4 2018 | $1,093,000 | -29.5% | 76,651 | +3.0% | 0.01% | -14.3% |
| Q3 2018 | $1,550,000 | +1.5% | 74,451 | +15.3% | 0.01% | 0.0% |
| Q2 2018 | $1,527,000 | +1227.8% | 64,551 | +136.5% | 0.01% | +600.0% |
| Q1 2014 | $115,000 | -8.7% | 27,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $126,000 | -33.3% | 27,300 | -10.5% | 0.00% | 0.0% |
| Q3 2013 | $189,000 | – | 30,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |